Filing Details
- Accession Number:
- 0001209191-23-016087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 20:53:57
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-03 20:53:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1653087 | Alector Inc. | ALEC | Biological Products, (No Disgnostic Substances) (2836) | 822933343 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1895592 | Sara Kenkare-Mitra | C/O Alector, Inc. 131 Oyster Point Blvd., Suite 600 South San Francisco CA 94080 | President And Head Of R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-02 | 10,124 | $8.32 | 188,241 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.
Billionaire Hedge Funds
